Dark

DXR
Daxor Corporation Common Stock
stock NASDAQ

At Close

Jul 31, 2026 3:57:53 PM EDT

10.75USD+2.089%(+0.22)688

7.31Bid 13.68Ask 6.37Spread

Pre-market

0.00USD-100.000%(-10.53)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 21, 2022

08:00AM EST Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD, MPA to its Board of Directors, effective January 18, 2022. GlobeNewswire Inc

Jan 20, 2022

04:05PM EST Daxor Corporation to Commence Trading on The Nasdaq Capital Market GlobeNewswire Inc

Jan 19, 2022

09:02AM EST Dynamic Funds announces January 2022 cash distributions for Dynamic Active ETFs PR Newswire

Jan 6, 2022

08:00AM EST Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 13, 2022. GlobeNewswire Inc

Jan 5, 2022

08:06AM EST Daxor Announces Completion Of Patient Enrollment In Multicenter BVA-100 Study In Hospitalized Patients With COVID-19 Benzinga

08:00AM EST Patient Enrollment Complete and Data Analysis Commences with Daxors Blood Volume Analysis Technology GlobeNewswire Inc

Jan 4, 2022

08:11AM EST Daxor Awarded U.S. Patent For Blood Volume Guidance Technology To Improve Treatment And Outcomes Benzinga

08:00AM EST Method Patent Covers Blood Volume Analysis Technology to Evaluate and Guide Treatment Decisions in Multiple Medical Conditions GlobeNewswire Inc

Dec 30, 2021

09:00AM EST Dynamic Funds announces final year-end cash distributions for Dynamic Active PR Newswire

09:00AM EST Dynamic Funds announces final year-end reinvested distributions for the Dynamic PR Newswire

Dec 22, 2021

09:01AM EST Dynamic Funds announces estimated year-end cash distributions for Dynamic PR Newswire

09:01AM EST Dynamic Funds announces estimated year-end reinvested distributions for Dynamic PR Newswire

Nov 17, 2021

09:00AM EST Dynamic Funds announces November 2021 cash distributions for Dynamic Active ETFs PR Newswire

Nov 16, 2021

08:15AM EST Daxor Corporation Presents New Data Validating The Benefit Of The BVA-100 Blood Test For Optimal Heart Failure Management At Key Scientific Society Meeting Benzinga

08:01AM EST Two New Studies Presented at the American Heart Association Scientific Sessions 2021, Adoption of Technology Reported as Excellent and Valuable by Lead Authors GlobeNewswire Inc

Nov 9, 2021

08:00AM EST Data Presented at the NeuroCritical Care Society 19th Annual Meeting 2021 GlobeNewswire Inc

Oct 19, 2021

09:00AM EDT Dynamic Funds Announces October 2021 Cash Distributions for Dynamic Active ETFs PR Newswire

Oct 1, 2021

08:30AM EDT The SBIR/STTR Matching Fund Grant Will Advance the Companys Innovation and Commercialization Efforts, and Job Creation GlobeNewswire Inc

Sep 20, 2021

09:02AM EDT Dynamic Funds announces September 2021 cash distributions for Dynamic Active PR Newswire

Sep 14, 2021

08:34AM EDT Daxor Highlights Presentation Of BVA-100 Blood Test Data At Heart Failure Society of America Annual Scientific Meeting 2021 Benzinga

08:30AM EDT Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Appropriate, Personalized Care to Patients with Heart Failure GlobeNewswire Inc

Sep 8, 2021

08:50AM EDT Daxor Corporation To Present New Data, Clinical Trials Utilizing BVA-100 Blood Test At Heart Failure Society Of America Annual Scientific Meeting 2021 Benzinga

08:30AM EDT Daxor Corporation To Present Compelling New Data and Clinical GlobeNewswire Inc

Sep 7, 2021

08:30AM EDT Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Michael Feldschuh will present at the 23rd Annual H.C. Wainwright Global Investment Conference which is being held virtually from September 13-15, 2021. GlobeNewswire Inc

Sep 1, 2021

08:33AM EDT Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders Benzinga

08:30AM EDT Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on form N-CSR on August 30, 2021, from CEO & President, Michael Feldschuh: GlobeNewswire Inc

Aug 30, 2021

08:36AM EDT Daxor Reports 26.5% Rise In Diagnostic Sales Revenue For 6 Months Ending June 30, 2021 Benzinga

08:30AM EDT Company forecasts further increase in sales driven by new distributor agreements GlobeNewswire Inc

Aug 19, 2021

09:01AM EDT Dynamic Funds announces August 2021 cash distributions for Dynamic Active ETFs PR Newswire

Aug 4, 2021

09:31AM EDT Daxor Earlier Highlighted Publication Of BVA-100 Data In Journal Critical Care Benzinga

08:30AM EDT Daxors Blood Volume (BVA-100) GlobeNewswire Inc

Jul 22, 2021

08:32AM EDT Daxor Announces Non-Government Distribution Agreement With Concordance Healthcare Solutions Benzinga

08:30AM EDT DAXOR CORPORATION ANNOUNCES NON-GOVERNMENT DISTRIBUTION AGREEMENT GlobeNewswire Inc

Jul 20, 2021

09:02AM EDT Dynamic Funds announces July 2021 cash distributions for Dynamic Active ETFs PR Newswire

May 28, 2021

08:30AM EDT Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxors President and Chief Executive Officer will present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being held virtually on June 2, 2021 at 4:30 PM ET. GlobeNewswire Inc

May 17, 2021

09:28AM EDT Dynamic Funds announces May 2021 cash distributions for Dynamic Active ETFs PR Newswire

May 13, 2021

08:30AM EDT Daxor Corporation Announces 61% Increase in Q1 2021 Sales Revenue GlobeNewswire Inc

May 6, 2021

08:54AM EDT Daxor Corporation Says Receives National Institutes Of Health Funding Notification For Landmark Multi-Center Heart Failures Trial Utilizing BVA-100 With U.S. Department Of Veterans Affairs Benzinga

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis guided management of acute decompensated heart failure (ADHF) utilizing the BVA-100 blood test. GlobeNewswire Inc

Apr 29, 2021

08:57AM EDT Daxor Highlights Publication Of BVA-100 Study In Journal Of The American College Of Cardiology Benzinga

08:31AM EDT Daxor Corporation(NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility of the BVA-100 blood test in postural tachycardia syndrome (POTS) published in the Journal of the American College of Cardiology from the Vanderbilt Autonomic Dysfunction Center in Nashville, TN. GlobeNewswire Inc

Apr 20, 2021

09:04AM EDT Dynamic Funds announces April 2021 cash distributions for Dynamic Active ETFs PR Newswire

Apr 9, 2021

09:00AM EDT TMX Group Equity Financing Statistics - March 2021 PR Newswire

Apr 8, 2021

11:30AM EDT Dynamic Funds Virtually Opens The Market PR Newswire

Mar 31, 2021

08:30AM EDT Dynamic Funds further expands its Active ETF line-up with launch of two new PR Newswire

Mar 25, 2021

02:45PM EDT Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference Benzinga

12:02PM EDT Ascendiant Capital Assumes Daxor at Buy, Announces Price Target of $21 Benzinga

11:26AM EDT Daxor Biotech Blood Volume Innovation Is Rapidly Improving Patient Outcomes Benzinga

Mar 23, 2021

07:12PM EDT Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021 Benzinga

Mar 18, 2021

08:30AM EDT Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will participate in the Benzinga Biotech Small Cap Conference to be held March 24th to 25th, 2021. Mr. Feldschuh will present on March 24th at 12:30 PM EDT. GlobeNewswire Inc

Mar 16, 2021

08:30AM EDT Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at Maxim Group 2021 Emerging Growth Virtual Conference to be held March 17-19, 2021, 9:00 AM - 5:00 PM EST. GlobeNewswire Inc

Mar 15, 2021

08:39AM EDT Daxor Corporation Announces Novel Fluorescent Tracer and Phase-two Us Air Force Contract Award of $750K for Point-of-care Optical Blood Volume Analyzer Benzinga

08:30AM EDT DAXOR CORPORATION ANNOUNCES NOVEL FLUORESCENT TRACER AND PHASE-TWO GlobeNewswire Inc

Mar 4, 2021

08:30AM EST Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at the H.C. Wainwright Global Life Sciences Conference which is being held from March 9th to 10th through a virtual format with on-demand video presentations. GlobeNewswire Inc

Feb 26, 2021

08:33AM EST Daxor Corp Reports FY 2020 NAV $3.89 Vs $3.41 YoY Benzinga

08:30AM EST Daxor Corporation Announces $0.48 Per Share NAV Increase and Files GlobeNewswire Inc

Feb 19, 2021

08:34AM EST Daxor Corporation Says Receives ISO 13485 Quality Management System Certification For Blood Volume Analyzer BVA-100 Benzinga

08:30AM EST DAXOR CORPORATION RECEIVES ISO 13485 QUALITY MANAGEMENT SYSTEM GlobeNewswire Inc

Feb 5, 2021

09:52AM EST DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING GlobeNewswire Inc

08:41AM EST Daxor Corporation Awarded Grant From The Center For Advancing Point Of Care Technologies (CAPCat) To Develop A Point-Of-Care Blood Volume Analyzer Benzinga

08:34AM EST Daxor Corp Says Awarded Grant From Center For Advancing Point Of Care Technologies To Develop A Point-Of-Care Blood Volume Analyzer Benzinga

Feb 4, 2021

08:37AM EST Daxor Corp Highlights New Research Demonstrating 'Clinical Utility With Daxor's Blood Volume Analyzer' In Critical Care Benzinga

08:30AM EST Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress GlobeNewswire Inc

Jan 26, 2021

08:30AM EST DAXOR CORPORATION TO EXHIBIT AT THE SOCIETY FOR CRITICAL CARE GlobeNewswire Inc

Jan 13, 2021

08:42AM EST Daxor Signs New Distribution Agreement With L1 Enterprises RTTNews

08:30AM EST DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH L1 ENTERPRISES GlobeNewswire Inc

Jan 8, 2021

08:30AM EST Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 GlobeNewswire Inc

Dec 10, 2020

08:33AM EST Daxor Corporation Announces Further Acquisitions Of Its BVA-100 Blood Volume Analyzer By Leading Medical Centers Throughout U.S. Benzinga

08:30AM EST Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces additional acquisitions of Daxors BVA-100 Blood Volume Analyzer at major medical centers across the U.S. GlobeNewswire Inc

Dec 9, 2020

08:30AM EST Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, Daxors President and Chief Executive Officer, will present at the virtual 2020 LD MicroCap Main Event on December 14, 2020 at 10:40 AM ET in Track One: Top Dollar. GlobeNewswire Inc

Nov 19, 2020

08:30AM EST THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100 GlobeNewswire Inc

Oct 29, 2020

08:30AM EDT COVID-19 Investigation Continues at OHSU to Study Hospitalized Patients Utilizing Daxors Blood Volume Analysis Technology GlobeNewswire Inc

Oct 12, 2020

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, Daxors President and Chief Executive Officer, will present at the virtual 2020 MicroCap Rodeo Best Ideas Bowl on Tuesday, October 13th at 3:00 PM ET. GlobeNewswire Inc

Oct 6, 2020

08:41AM EDT Daxor Corp. Says New Research Shows Co's BVA-100 Blood Test Provides Unique Benefit In Detecting Anemia, Heart Failure Risk, Presented At The Heart Failure Society Of America Meeting 2020 Benzinga

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data presented during the Heart Failure Society of Americas Annual Scientific Meeting focused on the use of Daxors BVA-100 blood test for uniquely measuring anemia. GlobeNewswire Inc

Oct 5, 2020

08:33AM EDT Daxor Corp Reports New Research Demonstrates Co's BVA-100 Blood Test Provides 'Extremely Cost-Effective' Improvement In Patient Life Span At The Heart Failure Society Of America Annual Scientific Meeting 2020 Benzinga

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces compelling new data demonstrating further beneficial use of Daxors blood volume analysis technology presented during the Heart Failure Society of Americas Virtual Annual Scientific Meeting 2020. GlobeNewswire Inc

Oct 2, 2020

08:33AM EDT Daxor Corp. Says New Data Released From Mayo Clinic Utilizing Co's BVA-100 Test Highlights Value Of Daxor's Diagnostic At The Heart Failure Society Of America Virtual Annual Scientific Meeting 2020 Benzinga

08:30AM EDT New Data Released from the Mayo Clinic Utilizing GlobeNewswire Inc

Sep 28, 2020

08:57AM EDT What Does Daxor's Debt Look Like? Benzinga

08:31AM EDT Daxor Corporation To Exhibit, Showcase Compelling New Data At Heart Failure Society Of America Virtual Annual Scientific Meeting 2020 On The Value Of BVA-100 Benzinga

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces the Company will be exhibiting and showcasing new data at the Heart Failure Society of Americas (HFSA) Virtual Annual Scientific Meeting 2020 taking place from September 30th - October 6th, 2020. GlobeNewswire Inc

Sep 15, 2020

08:30AM EDT Daxor to Present at the Inaugural Sepsis Alliance Summit GlobeNewswire Inc

Sep 10, 2020

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, Daxors President & Chief Executive Officer, will present at the virtual H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020, at 2:00 PM ET. GlobeNewswire Inc

Aug 31, 2020

08:30AM EDT Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that it will be presenting at the LD 500 Virtual Investor Conference scheduled to take place from September 1-4, 2020. GlobeNewswire Inc

Aug 24, 2020

08:37AM EDT Daxor Announces a 29.6% Increase in Revenue From its Diagnostic Division for 1H 2020 Benzinga

Aug 4, 2020

08:56AM EDT Daxor Corp. Earlier Reported Cooperative R&D Deal With The Uniformed Services University Of The Health Sciences Benzinga

08:00AM EDT DAXOR ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT GlobeNewswire Inc

Jul 20, 2020

09:14AM EDT Daxor Corporation Announces Pricing Of $7M Offering At $20/Share Benzinga

09:09AM EDT Daxor Corporation Announces Pricing of $7.0 Million Registered GlobeNewswire Inc

05:11AM EDT 80 Biggest Movers From Friday Benzinga

Jul 16, 2020

08:14AM EDT Daxor Announces Prospective Randomized Control Trial At Duke University Medical Center To Guide Volume Treatment In Heart Failure Patients Benzinga

08:01AM EDT DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE GlobeNewswire Inc

Jul 15, 2020

08:18AM EDT Daxor Initiates Multicenter Prospective Study Utilizing BVA-100 Technology RTTNews

08:09AM EDT Daxor Announces Initiation Of First-Of-Its-Kind Multicenter BVA-100 Study In Hospitalized Patients With Coronavirus Benzinga

08:00AM EDT COVID-19 Investigation Commences at NYU Langone Health with Daxors Blood Volume Analysis Technology GlobeNewswire Inc